To investigate the impact of IBD on the circadian rhythms of the intestinal barrier, an in vitro IBD mimic condition was setup by treating Caco-2 cells with pro-inflammatory cytokines TNF-α and IL-17A [20], high levels of which are a key marker of immune dysregulation in IBD patients. Here, IL17A is linked to inflammatory bowel disease.